Stromal cells from human benign prostate hyperplasia produce A growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6

International Journal of Cancer

Volumn 68, Issue 2, 1996, Pages 207-214

  Degeorges, Armelle ^a   Tatoud, Roger ^a,c   Fauvel Lafeve, Françoise ^b   Podgorniak, Marie Pierre ^a   Millot, Guy ^a   De Cremoux, Patricia ^a   Calvo, Fabien ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c UF de Génétique Moléculaire HÔpital Lariboisière   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; STROMA CELL;

EID: 0029842864     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961009)68:2<207::AID-IJC12>3.0.CO;2-7     Document Type: Article

References (39)

1. AKIRA, S., HIRANO, T., TAGA, T. and KISHIMOTO, T., Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J., 4, 2860-2867 (1990).
2. BAGGIOLINI, M., DEWALD, B. and MOSER, B., Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol., 55, 97-179 (1994).
3. 1 phase of the cell cycle. Cancer Res., 51, 2379-2385 (1991).
4. BLAIS, Y., SUGIMOTO, K., CARRIÈRE, M.C., HAAGENSEN, D.E., LABRIE, F. and SIMARD, J., Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1α on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int. J. Cancer, 62, 732-737 (1995).
5. BORSELLINO, N., BELLDEGRUN, A. and BONAVIDA, B., Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res., 55, 4633-4639 (1995).
6. CAMPS, J.L., CHANG, S.M., HSU, T.C., FREEMAN, M.R., HONG, S.J., ZHAU, H., VON ESCHENBACH, A.C. and CHUNG, L.W.K., Fibroblastmediated acceleration of human epithelial tumor growth in vivo. Proc. not. Acad. Sci. (Wash.), 87, 75-79 (1990).
7. CHANG, S.H. and CHUNG, L.W.K., Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology, 125, 2719-2727 (1989).
8. CHIU, J.J., SGAGIAS, M.K. and COWAN, K.H., Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin. Cancer Res., 2, 215-221 (1996).
9. COHEN, P., PEEHL, D.M., BAKER, B., LIU, F., HINTZ, R.L. and ROSENFELD, R.G., Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia, J. clin. Endocrinol. Metab., 79, 1410-1415 (1994).
10. COMHAIRE, F., BOSMANS, E., OMBELET, W., PUNJABI, U. and SCHOONJANS, F., Cytokines in semen of normal men and of patients with andrological diseases. Amer. J. Reprod. Immunol., 31, 99-103 (1994).
11. CUSSENOT, O., BERTHON, P., BERGER, R., MOWSZOWICZ, I., FAILLE, A., HOJMAN, F., TEILLAC, P., LEDUC, A. and CALVO, F., Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J. Urol., 143, 881-886 (1991).
12. DANFORTH, D.N. and SGAGIAS, M.K., Interleukin-1α and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res., 53, 1538-1545 (1993).
13. DAVIS, L.G., DIBNER, M.D. and BATTEY, J.F., Basic methods in molecular biology, Elsevier, New York (1986).
14. DEGEORGES, A., HOFFSCHIR, F., CUSSENOT, O., GAUVILLÉ, C., LE DUC, A., DUTRILLAUX, B. and CALVO, F., Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line. Int. J. Cancer, 62, 724-731 (1995).
15. FORT, P., MARTY, L., PIECHACZYK, M., EL SABROUTY, S., DANI, C., JEANTEUR, P. and BLANCHARD, J.M., Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphatedehydrogenase multigenic family. Nucl Acids Res., 13, 1431-1442 (1985).
16. FRID, M.G., SHEKHONIN, B.V., KOTELIANSKY, V.E. and GLUKHOVA, M.A., Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev. Biol, 53, 185-193 (1992).
17. GLEAVE, M., HSIEH, J.T., GAO, C., VON ESCHENBACH, A.C. and CHUNG, L.W.K., Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51, 3753-3761 (1991).
18. HIRANO, T., Interleukin-6. In: A.W. Thompson (ed.), The cytokine handbook, p. 145, Academic Press, London (1994).
19. HUTCHINS, D. and STEEL, C.M., Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int. J. Cancer, 58, 80-84 (1994).
20. KABALIN, J.N., PEEHL, D.M. and STAMEY, T.A., Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate, 14, 251-263 (1989).
21. KOOISTRA, A., KÖNIG, J.J., KEIZER, D.M., ROMIJN, J.C. and SCHRÖDER, F.H., Inhibition of prostatic epithelial cell proliferation by a factor secreted specifically by prostatic stromal cells. Prostate, 26, 123-132 (1995).
22. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Land.), 227, 680-685 (1970).
23. LANDEGREN, U., Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of Iymphokines and cell surface antigens. J. Immunol. Meth., 67, 379-388 (1984).
24. MAY, L.T., SANTHANAM, U. and SEGHAL, P.B., On the multimeric nature of natural human interleukin-6. J. biol. Chem., 266, 9950-9955 (1991).
25. NG, S.B., TAN, Y.H. and GUY, G.R., Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J. biol. Chem., 269, 19021-19027 (1994).
26. PASSANITI, A., ISAACS, J.T., HANEY, J.A., ADLER, S.W., CUJDIK, T.J., LONG, P.V. and KLEINMAN, H.K., Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int. J. Cancer, 51, 318-324 (1992).
27. PIETRZKOWSKI, Z., MULHOLLAND, G., GOMELLA, L., JAMESON, B.A., WERNICKE, D. and BASERGA, R., Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor. Cancer Res., 53, 1102-1106 (1993).
28. PLOWMAN, G.D., GREEN, J.M., MCDONALD, V.L., NEUBAUER, M.G., DISTECHE, C.M., TODARO, G.J. and SHOYAB, M., The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol. cell. Biol., 10, 1969-1981 (1990).
29. ROWLEY, D.R., DANG, T.D., LARSEN, M., GERDES, M.J., MCBRIDE, L. and LU, B., Purification of a novel protein (ps20) from urogenital sinus mesenchymal cells with growth inhibitory properties in vitro. J. biol. Chem., 270, 22058-22065 (1995).
30. SHOYAB, M., MCDONALD, V.L., BRADLEY, J.G. and TODARO, G.J., Amphiregulin: a bifunctional growth-modulation glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc. nat. Acad. Sci. (Wash.), 85, 6528-6532 (1988).
31. SIEGALL, C.B., SCHWAB, G., NORDAN, R.P., FITZGERALD, D.J. and PASTAN, I., Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res., 50, 7786-7788 (1990).
32. SIEGSMUND, M.J., YAMAZAKI, H. and PASTAN, I., Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J. Urol., 151, 1396-1399 (1994).
33. SMITH, R.C., LITWIN, M.S., LU, Y. and ZETTER, B.R., Identification of an endogenous inhibitor of prostatic carcinoma cell growth. Nature (Med.), 1, 1040-1045 (1995).
34. STEINER, M.S., Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J. Urol., 153, 1085-1086 (1995).
35. TAMM, I., CARDINALE, I., KRUEGER, J., MURPHY, J.S., MAY, L.T. and SEGHAL, P.B., Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. exp. Med., 170, 1649-1669 (1989).
36. TAMM, I., CARDINALE, I. and MURPHY, J.S., Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc. nat. Acad. Sci. (Wash.), 88, 4414-4418 (1991).
37. TWILLIE, D.A., EISENBERGER, M.A., CARDUCCI, M.A., HSEIH, W.S., KIM, W.Y. and SIMONS, J.W., Interleukin-6: a candidate mediator of human prostate cancer morbidity. Urology, 45, 542-549 (1995).
38. VAN SNICK, J., CAYPHAS, S., VINK, A., UYTTENHOVE, C., COULIE, P.G., RUBIRA, M.R. and SIMPSON, R.J., Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. nat. Acad. Sci. (Wash.), 83, 9679-9683 (1986).
39. WILDING, G., ZUGMEIER, G., KNABBE, C., FLANDERS, K. and GELMANN, E., Differential effect of transforming growth factor β on human prostate cancer cells in vitro. Mol. cell. Endocrinol, 62, 79-87 (1989).